Estudo de Custo-efetividade Para o Sistema único de Saúde - SUS Sobre o Exame de Metabolismo de Glicose Marcada Com Flúor-18 Pela Tomografia de emissão de pósitron-PET
N/A
13 Years
N/A
13 Years
N/A
Not Enrolling
Both
Oncologic Patients
Both
Oncologic Patients
Trial Information
Estudo de Custo-efetividade Para o Sistema único de Saúde - SUS Sobre o Exame de Metabolismo de Glicose Marcada Com Flúor-18 Pela Tomografia de emissão de pósitron-PET
To provide detailed information about cost and effectiveness of FDG-PET in multiple
oncological diseases, such as Lymphoma, lung cancer and esophageal cancer.
Inclusion Criteria:
- Cancer
Exclusion Criteria:
- Other malignancy
- Uncontrolled Diabetes
- Pregnancy
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Authority:
Brazil: Ethics Committee
Study ID:
USP0460/05
NCT ID:
NCT01438164
Start Date:
June 2005
Completion Date:
September 2011
Related Keywords:
- Oncologic Patients
- FDG-PET
- cancer
- staging
- Evaluate the cost impact in the evaluation of oncologic patients.
Name | Location |
|---|
